We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

199 hedge funds and large institutions have $907M invested in Emergent Biosolutions in 2015 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 73 increasing their positions, 68 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

145% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 11

8% more funds holding

Funds holding: 184 → 199 (+15)

2.22% more ownership

Funds ownership: 81.84% → 84.06% (+2.2%)

7% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 68

1% more call options, than puts

Call options by funds: $658K | Put options by funds: $654K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

12% less capital invested

Capital invested by funds: $1.02B → $907M (-$118M)

Holders
199
Holders Change
+15
Holders Change %
+8.15%
% of All Funds
5.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
27
Increased
73
Reduced
68
Closed
11
Calls
$658K
Puts
$654K
Net Calls
+$4K
Net Calls Change
-$260K

Top Buyers

Rank Fund Capital Flow
1
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
+$14.4M
2
ICRM
Insight Capital Research & Management
California
+$6.8M
3
OAM
Oxford Asset Management
United Kingdom
+$6.78M
4
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado
Colorado
+$6.43M
5
GT
Glenmede Trust
Pennsylvania
+$5.33M

Top Sellers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
-$13.1M
2
BC
Broadfin Capital
New York
-$4.57M
3
GC
Guggenheim Capital
Illinois
-$4.14M
4
Goldman Sachs
Goldman Sachs
New York
-$3.95M
5
BIT
BlackRock Institutional Trust
California
-$2.88M
Name Holding Trade Value Shares
Change 		Change in
Stake
PPA
51
Parametric Portfolio Associates
Washington
$3.45M -$441K -13,372 -10%
TCIM
52
TIAA CREF Investment Management
New York
$3.4M -$183K -5,542 -4%
BIM
53
BlackRock Investment Management
Delaware
$3.34M -$60.9K -1,848 -2%
CRC
54
Curi RMB Capital
Illinois
$3.32M +$271K +8,235 +8%
Bank of America
55
Bank of America
North Carolina
$3.27M +$2.27M +69,008 +151%
NI
56
Numeric Investors
Massachusetts
$2.9M -$1.49M -45,152 -31%
First Trust Advisors
57
First Trust Advisors
Illinois
$2.89M +$151K +4,595 +5%
SIM
58
Spark Investment Management
New York
$2.86M – – –
ZIM
59
Zacks Investment Management
Illinois
$2.83M +$1.48M +44,861 +82%
California Public Employees Retirement System
60
California Public Employees Retirement System
California
$2.82M +$234K +7,100 +8%
Axa
61
Axa
France
$2.8M +$237K +7,200 +8%
SCP
62
Seizert Capital Partners
Michigan
$2.72M -$428K -13,003 -12%
Two Sigma Investments
63
Two Sigma Investments
New York
$2.68M -$1.54M -46,837 -33%
CAM
64
ClariVest Asset Management
California
$2.47M -$65.9K -2,000 -2%
Millennium Management
65
Millennium Management
New York
$2.37M +$2.73M +82,995 New
NFA
66
Nationwide Fund Advisors
Ohio
$2.21M – – –
BA
67
BlackRock Advisors
Delaware
$2.18M +$196K +5,935 +8%
TC
68
TFS Capital
Pennsylvania
$2.06M +$2.04M +61,901 +599%
New York State Common Retirement Fund
69
New York State Common Retirement Fund
New York
$1.99M -$2.3M -69,790 -50%
Comerica Bank
70
Comerica Bank
Texas
$1.94M -$2.85M -86,636 -56%
QI
71
QS Investors
New York
$1.9M +$2.2M +66,800 New
TI
72
Turner Investments
Pennsylvania
$1.86M – – –
Jacobs Levy Equity Management
73
Jacobs Levy Equity Management
New Jersey
$1.68M -$1.55M -47,170 -44%
VOYA Investment Management
74
VOYA Investment Management
Georgia
$1.66M -$123K -3,743 -6%
State Board of Administration of Florida Retirement System
75
State Board of Administration of Florida Retirement System
Florida
$1.65M -$2.11K -64 -0.1%
1 2
3
4 5

EBS Hedge Fund Activity: Q3 2015 in Review

199 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q3 2015, worth a combined $907M — down 12% from $1.02B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new EBS positions and 11 closed out — a net gain of 16 holders — while 73 added to existing stakes and 68 trimmed.

The largest buyer was Manulife (Manufacturers Life Insurance), adding an estimated $14.4M. The largest seller was Bank of New York Mellon, cutting an estimated $13.1M.

  • 199 institutional investors held Emergent Biosolutions (EBS) as of Q3 2015, up from 184 in Q2 2015.
  • Funds reported $907M of Emergent Biosolutions stock for Q3 2015, down 12% quarter-over-quarter.
  • 27 funds opened new Emergent Biosolutions positions in Q3 2015 and 11 closed out, a net change of +16 holders.
  • The largest Emergent Biosolutions buyer in Q3 2015 was Manulife (Manufacturers Life Insurance), an estimated $14.4M added.
  • The largest Emergent Biosolutions seller in Q3 2015 was Bank of New York Mellon, an estimated $13.1M sold.

Based on aggregated 13F filings for Q3 2015.